The latest report by IMARC Group, titled "Separation Systems for Commercial Biotechnology Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," finds that the global separation systems for commercial biotechnology market size reached US$ 25.3 Billion in 2022. Separation systems for commercial biotechnology are solutions used to purify and separate biological products from complex mixtures and solutions such as diagnostic reagents, biochemicals, and biopharmaceuticals. It includes various equipment and devices, such as membranes, filters, centrifuges, chromatographs, biochips, and microarrays. These solutions also offer various benefits, such as higher recovery and minimal waste generation. Owing to these properties, separation systems find extensive applications across pharmaceutical, food and beverage (F&B), cosmetic, and agriculture industries.
Global Separation Systems for Commercial Biotechnology Market Trends:
The market is primarily driven by the expanding pharmaceutical industry. In addition, the escalating demand for personalized drugs, biopharmaceuticals, and cell-based therapies due to the increasing prevalence of chronic medical ailments represents another major growth-inducing factor. Besides this, various technological advancements, including the development of innovative upstream bioprocessing technologies that eliminate biohazardous by-products using simplified procedures, are contributing to the market growth. Moreover, the improving healthcare infrastructure, especially in developing countries, and extensive research and development (R&D) in the field of biotechnology are also creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market value to reach US$ 36.1 Billion by 2028, exhibiting a CAGR of 5.94% during the forecast period (2023-2028).
- Based on the method, the market has been bifurcated into modern methods (microarray, lab-on-a-chip, magnetic separation, and others) and conventional methods (chromatography, flow cytometry, membrane filtration, and others).
- On the basis of the application, the market has been classified into pharmaceutical (vaccines, proteins, hormones and insulin, enzymes, human blood plasma fractionation, and mammalian cell cultures), food and cosmetics, agriculture, and others.
- Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has been examined in the report, with some of the key players being Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific.
|Base Year of the Analysis
||Methods, Application, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800